Back
Merck & Co., Inc. 10K Form
Buy
51
MRK
Merck & Co., Inc.
Last Price:
$121.48
Seasonality Move:
2.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2026-01-15 | 10K | MRK/Merck & Co., Inc. Annual |
| 2025-12-15 | 10K | MRK/Merck & Co., Inc. Annual |
| 2025-11-15 | 10K | MRK/Merck & Co., Inc. Annual |
| 2025-10-15 | 10K | MRK/Merck & Co., Inc. Annual |
| 2025-09-15 | 10K | MRK/Merck & Co., Inc. Annual |
| 2025-08-15 | 10K | MRK/Merck & Co., Inc. Annual |
Receive MRK News And Ratings
See the #1 stock for the next 7 days that we like better than MRK
MRK Financial Statistics
Sales & Book Value
| Annual Sales: | $65B |
|---|---|
| Cash Flow: | $6.8B |
| Price / Cash Flow: | 21.89 |
| Annual Sales: | $20.85 |
| Price / Book: | 5.81 |
Profitability
| EPS (TTM): | 7.27510 |
|---|---|
| Net Income (TTM): | $18.3B |
| Gross Margin: | $53B |
| Return on Equity: | 39.63% |
| Return on Assets: | 15.24% |
Merck & Co., Inc. Earnings Forecast
Key Merck & Co., Inc. Financial Ratios
-
The Gross Profit Margin over the past 46 years for MRK is 81.50%.
-
The Selling, General & Administrative Expenses for MRK have been equal to 16.51% of Gross Profit Margin.
-
The Research & Development expenses have been 23.99% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of MRK is 28.09% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 24 years.
Merck & Co., Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | MRK |
| CUSIP: | 58933Y |
| Website: | merck.com |
Debt
| Debt-to-Equity Ratio: | 0.8 |
|---|---|
| Current Ratio: | 1.66 |
| Quick Ratio: | 1.06 |
Price-to-Earnings
| Trailing P/E Ratio: | 16.67 |
|---|---|
| Forward P/E Ratio: | 12.41 |
MRK Technical Analysis vs Fundamental Analysis
Buy
51
Merck & Co., Inc. (MRK)
is a Buy
Is Merck & Co., Inc. a Buy or a Sell?
-
Merck & Co., Inc. stock is rated a BuyThe current Merck & Co., Inc. [MRK] share price is $121.41. The Score for MRK is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.